Table of Contents Table of Contents
Previous Page  675 692 Next Page
Information
Show Menu
Previous Page 675 692 Next Page
Page Background

1.

Introduction

Stress urinary incontinence (SUI) is the predominant form

of urinary incontinence. Depending on age, the prevalence

ranges from 29–75%, with a mean of 48%

[1]

. Several

surgical options for treating SUI, after failure of conserva-

tive measures, are available. According to the 2013 update

of the International Consultation on Incontinence guide-

lines, the surgical treatments of SUI may include the use of

bulking agents, midurethral slings (MUSs), and colposus-

pension

[2]

. It has been widely demonstrated that MUSs

are the most effective and safe surgical procedures for the

management of SUI compared with other techniques

[3]

. Several randomized controlled trials showed that

transobturator insertion of a synthetic MUS gave equiva-

lent patient-reported and clinician-reported cure rates at

short- to medium-term follow-up compared with retro-

pubic insertion

[4]

. Although the long-lasting benefits of

the retropubic route have been adequately evaluated

[5,6]

,

long-term outcomes for the transobturator route need to

be addressed.

Only six studies have assessed medium-term outcomes

of the tension-free vaginal tape–obturator (TVT-O)

procedure, with a maximum follow-up period of 5 yr

[7–12]

. In some of these studies, women with overactive

bladder (OAB) symptoms or with urodynamically proven

detrusor overactivity (DO) were included

[8,9,12]

. To date,

the available evidence concerning long-term outcomes of

TVT-O is limited at two studies. In one of these, Athanasiou

et al

[13]

reported subjective and objective cure rates of

124 TVT-O procedures at 7-yr follow-up of 83.5% and

81.5%, respectively; however, this retrospective analysis

included 93 procedures associated with concomitant

prolapse surgery. In the other prospective, multicenter

clinical trial

[14] ,

47 TVT-O procedures were evaluated

with median follow-up of 100 mo, and a subjective cure

rate of 59.6% and an objective cure rate of 70.2% were

found; the authors also considered women with mixed

urinary incontinence. We have published a prospective,

multicenter study to evaluate transobturator tape for the

treatment of SUI at 5-yr follow-up

[7]

. The aim of the

present multicenter study is to report, for the first time in

the available literature to our knowledge, the long-term

objective and subjective outcomes of women with TVT-O

implantation for pure SUI with follow-up of 10 yr to

assess the efficacy and safety of this procedure in the case

of pure SUI.

2.

Materials and methods

This was a multicenter, prospective study at five tertiary referral

centers in three countries. From January 2004, we have enrolled all

consecutive women with pure SUI symptoms with urodynamically

proven urodynamic stress incontinence (USI). All patients recom-

mended for surgery were scheduled for a TVT-O procedure (Gynecare

TVT Obturator System; Ethicon Inc., Somerville, NJ, USA). Exclusion

criteria were as follows: women with a history of radical pelvic

surgery, psychiatric or neurologic disorders, concomitant vaginal

prolapse greater than stage 1 according to the pelvic organ prolapse

(POP) quantification (POP-Q) system

[15] ,

OAB symptoms, urodyna-

mically proven DO, and postvoid residual urine volume

>

100 ml

[16] .

Preoperative evaluation included medical history, physical exami-

nation, a voiding diary, urinalysis, and complete urodynamic testing.

Physical examination was performed with the patient in the lithotomy

position, and POP was described during a maximal Valsalva maneuver

according to the POP-Q system

[15] .

All women were evaluated by a

trained urogynecologist with urodynamic studies as previously

described

[17]

(including uroflowmetry, filling cystometry, Valsalva

leak-point pressure [VLPP] measurement, and pressure/flow study),

using a standardized protocol in accordance with the good urodynamic

practice guidelines of the International Continence Society

[18] .

Ure-

thral hypermobility was defined by a Q-tip test result

>

30

8

. Patients

were included regardless of Q-tip test results and VLPP values. All

methods, definitions, and units were updated in agreement with the

last version of the International Continence Society standardization of

terminology

[19] .

All patients also completed the International

Consultation on Incontinence Questionnaire–Short Form (ICIQ-SF)

questionnaire

[20] .

All the TVT-O procedures were performed according to the

technique originally described by De Leval

[21] ,

using the inside-out

approach. The procedure uses a polypropylene sling with two arms

that are passed inside to outside through the obturator foramens,

pulled to compress the bulbar urethra upward, and tied to each other

across the midline. General or spinal anesthesia was used in

accordance with the anesthesiologic requirements and/or the patient’s

preference, as previously reported

[22] .

Postoperative evaluations

were mandatory at 12 mo, 60 mo, and 120 mo in all centers, and

intermediate visits were scheduled at the physician’s discretion. Every

follow-up visit included medical history, physical examination,

voiding diary, stress test, and evaluation of subjective satisfaction. A

stress test was performed in the lithotomy and upright positions with a

full bladder (ultrasonographic measurement 400 ml). Objective cure

was defined as the absence of urine leakage during the stress test. To

define the subjective outcomes at 1, 5, and 10 yr, all patients completed

the ICIQ-SF, the Patient Global Impression of Improvement (PGI-I)

scale (a 7-point scale, with a range of responses from 1, ‘‘very much

improved,’’ through 7, ‘‘very much worse’’)

[23]

, and a patient

satisfaction scale (a single, self-answered, Likert-type scale of 0–10

that grades the patient’s degree of satisfaction regarding continence:

0 indicates ‘‘not satisfied,’’ and 10, ‘‘satisfied’’)

[24] .

Subjective success

was indicated both by ‘‘very much improved’’ or ‘‘much improved’’

(PGI-I score 2) and by a patient satisfaction score 8, as previously

described in 2011 by Abdel-Fattah et al

[25]

.

The Declaration of Helsinki was followed, and preoperative written

informed consent for TVT-O implantation was obtained from all patients

in this observational prospective evaluation.

2.1.

Statistical analysis

Statistical analysis was performed with IBM-SPSS v.17 for Windows (IBM

Corp, Armonk, NY, USA). Continuous variables were reported as median

and interquartile range. We used the

x

2

test and

x

2

test for trend to

analyze and compare the surgical outcomes during the follow-up. The

x

2

test for trend can better assess if the success of the surgical procedure

tends to decrease over time, comparing the cure rates at the different

follow-up visits (1, 5, and 10 yr). The null hypothesis is that there is not an

association between the cure rate of TVT-O and the time. One-way

analysis of variance was used to compare continuous series of variables in

the comparison of the scores used to measure the subjective outcomes.

The Cox proportional hazards model was used for univariate analysis to

evaluate factors potentially affecting the risk of recurrence (subjective or

objective) during the study period. Statistical significance was considered

achieved when

p

<

0.05.

E U R O P E A N U R O L O G Y 7 1 ( 2 0 1 7 ) 6 7 4 – 6 7 9

675